Increased MGO formation or decreased GLO1 activity leads to the accumulation of AGE-modified proteins in the body which is the hallmark of many age-related diseases, such as obesity, cardiovascular and renal disease, or diabetes and its vascular complications [5,6,7,8,9]. Here, GLO1 is linked to kidney disorder.